Arca
Skip to content

Sauflon Clariti 1 Day (Somofilcon A) Soft (Hydrophilic) Daily Disposable Contact Lens With Uv Blocker

Lens, Contact, (Disposable). 510(k) K130331, from Sauflon Pharmaceuticals, Ltd. (Twickenham, Middlesex, GB). Product code MVN, class 2.

As of Nov 17, 2026, K130331 is an FDA 510(k) held by Sauflon Pharmaceuticals, Ltd., substantially equivalent on Jul 26, 2013 after 165 days, with 17 recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jul 26, 2013
  • Review time: 165 days
  • Recalls: 17
  • Cited as a predicate by: 3 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

Sauflon Clariti 1 Day (somofilcon A) Soft (hydrophilic) Daily Disposable Contact Lens with UV blocker is indicated for: The SAUF LON CLARITI 1 DAY (somofilcon A) Soft (hydrophilic) Daily Disposable Contact Lens with UV blocker is indicated for daily wear single use only for the correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes that may…

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K130331, newest first; each opens FDA's recall record
Aug 12, 2026Z-3248-2026A small number of lenses within the affected lot are of the incorrect power.Open, Classified
May 19, 2021Z-2150-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2147-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2151-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2152-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2143-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2146-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2148-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2154-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2149-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2145-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2144-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
May 19, 2021Z-2153-2021Misaligned placement of an axis mark can cause the patient to experience blurred visionTerminated
Feb 21, 2018Z-1516-2018The secondary packaging is labeled with an incorrect expiration date.Terminated
Feb 21, 2018Z-1515-2018The secondary packaging is labeled with an incorrect expiration date.Terminated
Feb 21, 2018Z-1517-2018The secondary packaging is labeled with an incorrect expiration date.Terminated
Feb 21, 2018Z-1518-2018The secondary packaging is labeled with an incorrect expiration date.Terminated

Other MVN Clearances

The newest 510(k)s for the same product code; see every MVN device

Record

Type
Traditional
Received
Feb 11, 2013
Review panel
Ophthalmic
Regulation
21 CFR 886.5925

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.